176 related articles for article (PubMed ID: 31201188)
1. Six versus two weeks treatment with doxycycline in Lyme neuroborreliosis: the protocol of a multicentre, non-inferiority, double-blinded and randomised controlled trial.
Solheim AM; Ljøstad U; Mygland Å
BMJ Open; 2019 Jun; 9(6):e027083. PubMed ID: 31201188
[TBL] [Abstract][Full Text] [Related]
2. Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial.
Ljøstad U; Skogvoll E; Eikeland R; Midgard R; Skarpaas T; Berg A; Mygland A
Lancet Neurol; 2008 Aug; 7(8):690-5. PubMed ID: 18567539
[TBL] [Abstract][Full Text] [Related]
3. Antibiotics for the neurological complications of Lyme disease.
Cadavid D; Auwaerter PG; Rumbaugh J; Gelderblom H
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD006978. PubMed ID: 27931077
[TBL] [Abstract][Full Text] [Related]
4. Oral doxycycline for Lyme neuroborreliosis with symptoms of encephalitis, myelitis, vasculitis or intracranial hypertension.
Bremell D; Dotevall L
Eur J Neurol; 2014 Sep; 21(9):1162-7. PubMed ID: 24684211
[TBL] [Abstract][Full Text] [Related]
5. Oral Doxycycline Compared to Intravenous Ceftriaxone in the Treatment of Lyme Neuroborreliosis: A Multicenter, Equivalence, Randomized, Open-label Trial.
Kortela E; Kanerva MJ; Puustinen J; Hurme S; Airas L; Lauhio A; Hohenthal U; Jalava-Karvinen P; Nieminen T; Finnilä T; Häggblom T; Pietikäinen A; Koivisto M; Vilhonen J; Marttila-Vaara M; Hytönen J; Oksi J
Clin Infect Dis; 2021 Apr; 72(8):1323-1331. PubMed ID: 32133487
[TBL] [Abstract][Full Text] [Related]
6. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis.
Mygland A; Ljøstad U; Fingerle V; Rupprecht T; Schmutzhard E; Steiner I;
Eur J Neurol; 2010 Jan; 17(1):8-16, e1-4. PubMed ID: 19930447
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infection.
Bremell D; Mattsson N; Edsbagge M; Blennow K; Andreasson U; Wikkelsö C; Zetterberg H; Hagberg L
BMC Neurol; 2013 Jan; 13():2. PubMed ID: 23294475
[TBL] [Abstract][Full Text] [Related]
8. Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
Halperin JJ; Shapiro ED; Logigian E; Belman AL; Dotevall L; Wormser GP; Krupp L; Gronseth G; Bever CT;
Neurology; 2007 Jul; 69(1):91-102. PubMed ID: 17522387
[TBL] [Abstract][Full Text] [Related]
9. Serum neurofilament light chain associates with symptom burden in Lyme neuroborreliosis patients: a longitudinal cohort study from Norway.
Skarstein I; Ulvestad E; Solheim AM; Vedeler C; Ljøstad U; Mygland Å; Eikeland R; Reiso H; Lorentzen ÅR; Bos SD
J Neurol; 2024 May; 271(5):2768-2775. PubMed ID: 38407594
[TBL] [Abstract][Full Text] [Related]
10. Lyme neuroborreliosis: do we treat according to guidelines?
Lorentzen ÅR; Forselv KJN; Helgeland G; Salvesen RE; Sand G; Flemmen HØ; Bø MH; Nordaa L; Roos AK; Jim MW; Owe JF; Nyquist KB; Schüler S; Eikeland R; Mygland Å; Ljøstad U
J Neurol; 2017 Jul; 264(7):1506-1510. PubMed ID: 28676925
[TBL] [Abstract][Full Text] [Related]
11. Persistent Lyme Empiric Antibiotic Study Europe (PLEASE)--design of a randomized controlled trial of prolonged antibiotic treatment in patients with persistent symptoms attributed to Lyme borreliosis.
Berende A; ter Hofstede HJ; Donders AR; van Middendorp H; Kessels RP; Adang EM; Vos FJ; Evers AW; Kullberg BJ
BMC Infect Dis; 2014 Oct; 14():543. PubMed ID: 25318999
[TBL] [Abstract][Full Text] [Related]
12. [Neuroborreliosis - Diagnostics, treatment and course].
Dersch R; Rauer S
Nervenarzt; 2017 Apr; 88(4):419-431. PubMed ID: 28175945
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of pharmacological treatments for acute Lyme neuroborreliosis - a systematic review.
Dersch R; Freitag MH; Schmidt S; Sommer H; Rauer S; Meerpohl JJ
Eur J Neurol; 2015 Sep; 22(9):1249-59. PubMed ID: 26058321
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of pharmacological treatments for neuroborreliosis--protocol for a systematic review.
Dersch R; Freitag MH; Schmidt S; Sommer H; Rücker G; Rauer S; Meerpohl JJ
Syst Rev; 2014 Oct; 3():117. PubMed ID: 25336085
[TBL] [Abstract][Full Text] [Related]
15. Intravenous ceftriaxone compared with oral doxycycline for the treatment of Lyme neuroborreliosis.
Borg R; Dotevall L; Hagberg L; Maraspin V; Lotric-Furlan S; Cimperman J; Strle F
Scand J Infect Dis; 2005; 37(6-7):449-54. PubMed ID: 16012005
[TBL] [Abstract][Full Text] [Related]
16. Doxycycline-mediated effects on persistent symptoms and systemic cytokine responses post-neuroborreliosis: a randomized, prospective, cross-over study.
Sjöwall J; Ledel A; Ernerudh J; Ekerfelt C; Forsberg P
BMC Infect Dis; 2012 Aug; 12():186. PubMed ID: 22876748
[TBL] [Abstract][Full Text] [Related]
17. Duration of antibiotic treatment in disseminated Lyme borreliosis: a double-blind, randomized, placebo-controlled, multicenter clinical study.
Oksi J; Nikoskelainen J; Hiekkanen H; Lauhio A; Peltomaa M; Pitkäranta A; Nyman D; Granlund H; Carlsson SA; Seppälä I; Valtonen V; Viljanen M
Eur J Clin Microbiol Infect Dis; 2007 Aug; 26(8):571-81. PubMed ID: 17587070
[TBL] [Abstract][Full Text] [Related]
18. Lyme neuroborreliosis: a treatable cause of acute ocular motor disturbances in children.
Correll MH; Datta N; Arvidsson HS; Melsom HA; Thielberg AK; Bjerager M; Brodsky MC; Saunte JP
Br J Ophthalmol; 2015 Oct; 99(10):1401-4. PubMed ID: 25868792
[TBL] [Abstract][Full Text] [Related]
19. Follow-up of patients treated with oral doxycycline for Lyme neuroborreliosis.
Karkkonen K; Stiernstedt SH; Karlsson M
Scand J Infect Dis; 2001; 33(4):259-62. PubMed ID: 11345216
[TBL] [Abstract][Full Text] [Related]
20. [Lyme borreliosis in adults].
Ljøstad U; Mygland A
Tidsskr Nor Laegeforen; 2008 May; 128(10):1175-8. PubMed ID: 18480867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
